Teriflunomide (HMR1726) ( DrugBank: Teriflunomide )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	4

13. 多発性硬化症／視神経脊髄炎

臨床試験数 : 3,342 / 薬物数 : 2,355 - (DrugBank : 406) / 標的遺伝子数 : 269 - 標的パスウェイ数 : 241

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03198351 (ClinicalTrials.gov)	April 25, 2013	22/6/2017	An Observational Study on Teriflunomide-exposed Pregnancies	Teriflunomide Pregnancy Outcome Exposure Registry: An OTIS Autoimmune Diseases in Pregnancy Project	Multiple Sclerosis	Drug: Teriflunomide (HMR1726)	Sanofi	NULL	Recruiting	16 Years	N/A	Female	325		United States;Canada
2	NCT00803049 (ClinicalTrials.gov)	October 2006	1/12/2008	Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitt ...	Long-term Extension of the Multinational, Double-blind, Placebo Controlled Study EFC6049 (HMR1726D/3 ...	Multiple Sclerosis	Drug: Teriflunomide (HMR1726)	Sanofi	NULL	Completed	18 Years	55 Years	All	742	Phase 3	United States;Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Nethe ...
3	NCT00228163 (ClinicalTrials.gov)	January 2002	26/9/2005	Long Term Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses	Extension of Protocol HMR1726D/2001, A Phase II Study of the Safety and Efficacy of Teriflunomide (H ...	Multiple Sclerosis	Drug: teriflunomide (HMR1726)	Sanofi	NULL	Completed	18 Years	65 Years	Both	147	Phase 2	Canada;France
4	NCT01487096 (ClinicalTrials.gov)	April 2001	5/12/2011	Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses	A Phase II Study of the Safety and Efficacy of Teriflunomide (HMR1726)in Multiple Sclerosis With Rel ...	Multiple Sclerosis	Drug: Teriflunomide;Drug: Placebo (placebo for teriflunomide)	Sanofi	NULL	Completed	18 Years	65 Years	Both	179	Phase 2	Canada;France

First Previous1Next Last